Latest Breaking News On - Relievant medsystems - Page 7 : comparemela.com

Boston Scientific stock rises on strong Q3, raised EPS guidance

Boston Scientific (NYSE: BSX) shares ticked up today on third-quarter results that came in ahead of the consensus forecast.

5 spine, orthopedic procedures securing payer coverage this year

This year 5 new procedures have secured coverage from major payers, including Relievant Medsystems Intracept spine procedure, Centinel Spine s Prodisc device,

Boston Scientific working to tackle chronic pain

Boston Scientific Corp.’s plan to acquire Relievant Medsystems Inc. is part of its ongoing effort to address chronic pain which is significantly impacting the quality of life of millions of people. Relievant’s Intracept intraosseous nerve ablation system will give Boston Scientific another tool in its armory to tackle chronic pain which already includes radiofrequency ablation (RFA) solutions and spinal cord stimulator (SCS) systems.

Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield

Intracept spine procedure earns coverage from Anthem Blue Cross and Blue Shield

Relievant Medsystems Intracept spine procedure earned a positive coverage policy from Anthem Blue Cross Blue Shield, the medtech company said Oct. 3.